about
Genome-wide analyses of Epstein-Barr virus reveal conserved RNA structures and a novel stable intronic sequence RNAUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseRecognition of human oncogenic viruses by host pattern-recognition receptorsBclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infectionMultiple functions are mediated by the miRNAs of Epstein-Barr virusExploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersThe Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic EventsProfessional antigen presenting cells in human herpesvirus 8 infection.Fresh Insights into Disease Etiology and the Role of Microbial Pathogens.Stable intronic sequence RNAs (sisRNAs): a new layer of gene regulation.Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes.EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.Outlooks on Epstein-Barr virus associated gastric cancer.Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.
P2860
Q21266670-1A56D31C-A66F-4627-BC21-3AF2EA7E5D45Q26823898-20CAE2F8-EF97-4672-B091-7091EAD5AB7DQ26998401-8AAEF7E2-B7E1-4380-BD9D-F33CEA4BFC5BQ27010116-A5096D2D-7A1F-4CAA-809C-91329D1379DAQ30519179-1B6E90FF-054C-4DA5-845D-83B0F8CF1423Q34112079-E2DE49A5-0926-48EE-9D26-ABAFDA9E27ECQ35738744-29359CA7-CF2F-4857-92EC-36219F752A9CQ35856872-AA88A8DF-8107-49A9-91E6-146E840C9A27Q36546999-E5C6CF58-83D8-4934-AD29-F4D049B7B9EBQ38678292-65A8F73F-389E-48FB-AD03-2F82394E1F2FQ38826164-BFC9BE06-72F4-4722-A969-2F6030B9C7BAQ38840238-051D8E50-8D6E-4060-ABCC-7ECD74656EF3Q38963370-2EDE55EF-B188-4A77-9377-3D87B6E5AD8AQ39219487-6A81D498-D38F-4C3B-B9CE-CD495A561287Q47224028-43ECE7EB-E74D-44C8-8664-3314926C163DQ47606332-E1CA592C-1F61-4795-B6F5-69F6FFF35685Q52720624-F0826634-897E-4229-AFB7-659326AFB119Q53693461-D2DA797A-C0D6-4D46-BDB2-B03650EFC1BA
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Innate immune modulation in EBV infection.
@en
Innate immune modulation in EBV infection.
@nl
type
label
Innate immune modulation in EBV infection.
@en
Innate immune modulation in EBV infection.
@nl
prefLabel
Innate immune modulation in EBV infection.
@en
Innate immune modulation in EBV infection.
@nl
P2860
P356
P1433
P1476
Innate immune modulation in EBV infection.
@en
P2093
Shunbin Ning
P2860
P2888
P356
10.1186/2042-4280-2-1
P577
2011-01-05T00:00:00Z
P5875
P6179
1024781701